1. Soporte circulatorio con ECMO venovenoso en paciente con síndrome de reperfusión pulmonar secundario a tromboendarterectomía arterial pulmonar.
- Author
-
Lazcano-Díaz, Emmanuel A., Encarnación-Martínez, Uriel, Gaytán-García, Cristhian J., Manzur-Sandoval, Daniel, González-Ruiz, Francisco J., García-Cruz, Edgar, Ramos-Enríquez, Ángel, Santos-Martínez, Luis E., Cota-Apodaca, Luis A., Hernández-Mejía, Benjamín I., Escamilla-Ríos, Dania E., and Rojas-Velasco, Gustavo
- Subjects
- *
VENOUS thrombosis , *EXTRACORPOREAL membrane oxygenation , *PULMONARY hypertension , *CARDIOGENIC shock , *PULMONARY artery , *SURGICAL complications , *ENDARTERECTOMY - Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) is a subtype of pulmonary hypertension characterized by the obstruction of pulmonary arteries secondary to chronic thromboembolism. Pulmonary thromboendarterectomy surgery (PTE) is the main treatment for patients with CTEPH, as it removes the chronic thrombi from the pulmonary arteries. Pulmonary reperfusion syndrome is a common complication of the surgery, which involves the development of pulmonary edema in the area where blood perfusion improves after the surgery. The incidence of this syndrome varies from 8 to 91% depending on the criteria used for diagnosis, and it is one of the most serious complications of pulmonary thromboendarterectomy. In such cases, circulatory support with extracorporeal membrane oxygenation (ECMO) has become a valuable therapeutic modality. We present the case of a 60-year-old woman with a history of acute pulmonary embolism due to deep vein thrombosis of the right pelvic limb who was diagnosed later with CTEPH who was admitted for scheduled surgical treatment involving bilateral PTE. However, during the immediate postoperative period, she developed cardiogenic shock and refractory hypoxemia secondary to pulmonary reperfusion syndrome following the surgical procedure. As a result, she required veno-venous ECMO circulatory support for 6 days, leading to resolution of the pulmonary condition and clinical improvement. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF